InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Kolchinsky Peter, Chief Executive Officer. Officer active across 2 companies, notably Forma Therapeutics Holdings, Inc.. In total, 6 disclosures have been published. Activity tracked since 17 June 2021. The latest transaction was filed on 29 June 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
209,100 shares@ US$10.009.5% of flowCommon StockSEC:0001104659-21-087618
209,100 shares@ US$10.009.5% of flowCommon StockSEC:0001104659-21-087618:0
889,218 shares@ US$10.0040.5% of flowCommon StockSEC:0001104659-21-085291
889,218 shares@ US$10.0040.5% of flowCommon StockSEC:0001104659-21-085291:0
2,750 shares0Common StockSEC:0000899243-21-025088
2,750 shares0Common StockSEC:0000899243-21-025088:0
6 of 6 declarations
About Kolchinsky Peter
Peter Kolchinsky is President and CEO at Forma Therapeutics Holdings, Inc. and Therapeutics Acquisition Corp. He is responsible for the strategic and operational direction of these companies, overseeing all activities to ensure growth and profitability. His leadership is essential for the success of the organization.
